IBB News 240.92 06/04/2014 05:06:49 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 240.92 $IBB

Look Abroad When You Have an American Trendless Market
at The Street - Tue Jun 03, 1:11PM CDT
You can't judge this market by the headlines. But India is showing much greater potential.

A Comprehensive Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri May 30, 7:00AM CDT
Despite recent volatility in the space, the longer-term fundamentals remain attractive.

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.48% Gain
Comtex SmarTrend(R) - Tue May 27, 4:18PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 27, 4:17PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $236.60 to a high of $240.68. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $236.28 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Fund (IBB) : Stop activated ($239.00)
Trading Central - Tue May 27, 10:00AM CDT
The ETF has reached our stop loss which was set at $239.00. Performance: -5.55%. Trading strategy: Stop activated ($239.00).

How Will Biotech Fare the Rest of the Year?
George Budwell, The Motley Fool - Motley Fool - Fri May 23, 5:30PM CDT
Biotech has had a fairly volatile year thus far. Shares of the closely watched iShares Nasdaq Biotech Index , for instance, have swung from double-digit gains to high single-digit losses at one point this year. With the index now roughly flat for...

iShares Nasdaq Biotechnology Index Rises 1.92% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu May 22, 3:44PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $229.00 to a high of $236.28. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $231.96 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.92%
Comtex SmarTrend(R) - Thu May 22, 3:43PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $229.00 to a high of $236.28. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $231.96 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Fund (IBB) : Short Sell @ $226.44
Trading Central - Thu May 15, 10:33AM CDT
From a technical view, the ETF is shaping a symmetrical triangle calling for the continuation of the previous bearish trend. Regarding technical indicators, the daily MACD is facing a strong resistance area while the daily RSI is reversing down from...

R.I.P. the Momentum Trade, 2012-2014
at The Street - Tue May 13, 1:39PM CDT
The momentum trade is dead. And a new momentum trade has risen to take its place.

iShares Nasdaq Biotechnology Index Fund (IBB) : Close former position at last price ($232.50)
Trading Central - Tue May 13, 9:10AM CDT
On a relative basis against the IVV S&P500, the iShares Nasdaq Biotechnology Index Fund is losing upward momentum since it is reversing down from a bearish trend line; we prefer to close our long position opened on April 22nd. Trading strategy: ...

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.42% Yesterday
Comtex SmarTrend(R) - Mon May 12, 4:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:03PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Growth Correction Over - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon May 12, 2:00PM CDT
Where are you finding GARP now?

Market Bulls Gather for Investors Rotating Portfolios
at The Street - Mon May 12, 12:04PM CDT
Despite all the recent divergences, the market is setting up for a bullish week.

Premier Biomedical Advances Technology via Partnerships
ACCESSWIRE - Fri May 09, 9:28AM CDT
Whitefish, MT / May 9, 2014 / Biotechnology stocks have had a rough quarter, with the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) falling more than 6% since February. Investors have started to re-evaluate the sector's lofty valuations, while higher interest rates in the near future could slow the M&A frenzy. As a result, investors may want to shift their attention to high-growth bargains in the industry.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.82%
Comtex SmarTrend(R) - Thu May 08, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.82%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Thu May 08, 3:49PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 43

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 23

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 32

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
Cogent Communications' Q3 2026 Earnings Call Details

Updated Category News Views 21

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 52

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 27

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 27

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 40

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Vayo Debuts as Booking Holdings Eyes $100M Investment

Updated Category News Views 23

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 32

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading

Top 5 Most Recently Viewed Articles

Jill Wagner's Patriotic Pick: A Celebration of Community and Valor

Updated Category News Views 207

Celebrating Community Through the Patriotic Pick Actress Jill Wagner is thrilled to host the 3rd Annual Patriotic Pick event at her beautiful Scott Mansion Farms. Set in a picturesque location, the event takes place on September 6 to bring together the community while supporting a cause that she deeply cherishes. This year, all proceeds will benefit the Special Operations...

Continue Reading
Teradata's Surge and Other Stocks to Watch in Early Trading

Updated Category News Views 181

Teradata Corp Posts Strong Financial Results Shares of Teradata Corp (NYSE:TDC) experienced a significant boost in pre-market trading after the company announced strong third-quarter financial results. The firm reported earnings of 72 cents per share, which outperformed analyst expectations of 54 cents. Additionally, Teradata generated quarterly revenues of $416 million,...

Continue Reading
AISpeech's Matrix Mic Celebrated in AV Awards 2026

Updated Category News Views 16

Breaking New Ground in AV Innovation Here's a little nugget for the tech-savvy folks out there. AISpeech is stepping up its game with the flagship MA600D Matrix Array Microphone, earning spots as a finalist in two categories at the AV Awards 2026. That's no small feat, especially for an industry bustling with innovation. These awards are like the Oscars for the AV sector,...

Continue Reading
Sunwest Bank Expands Colorado Reach with New Branches

Updated Category News Views 17

Bigger Footprint, Bigger Ambitions Sunwest Bank just made a hefty acquisition, scooping up the former MidWestOne and Bank of Denver branches from Nicolet National Bank. This move gives them a bigger bite out of the Rocky Mountain region, and let's not sugarcoat it—the stakes are high. Everyone from entrepreneurs to everyday folks is on their radar now. You see, Sunwest...

Continue Reading
Understanding Cooper Companies' P/E Ratio and Market Position

Updated Category News Views 275

Unpacking the Performance of Cooper Companies Inc. As we dive into the current trading conditions, it's important to understand how Cooper Companies Inc. (NASDAQ: COO) is positioned. The company's shares are currently trading around $74.52, marking a slight increase of 0.09%. Over the last month, we have observed a substantial climb of approximately 11.41%, contrasting...

Continue Reading